Related references
Note: Only part of the references are listed.Intravitreal diclofenac versus intravitreal bevacizumab in naive diabetic macular edema: a randomized double-masked clinical trial
Masoud Soheilian et al.
INTERNATIONAL OPHTHALMOLOGY (2015)
Pharmacological Approach to Diabetic Macular Edema
F. Bandello et al.
OPHTHALMIC RESEARCH (2014)
Intravitreal Injection of Commercially Available Ketorolac Tromethamine in Eyes with Diabetic Macular Edema Refractory to Laser Photocoagulation
Renata Malvezzi Maldonado et al.
CURRENT EYE RESEARCH (2011)
INTRAVITREAL DICLOFENAC VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN THE TREATMENT OF DIABETIC MACULAR EDEMA
Amal M. Elbendary et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process
Rita Ehrlich et al.
ACTA OPHTHALMOLOGICA (2010)
Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes
Naoko Endo et al.
ACTA OPHTHALMOLOGICA (2010)
Intravitreal injection of ketorolac tromethamine in patients with diabetic macular edema refractory to retinal photocoagulation
Andreia do Ceu Afonso Reis et al.
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA (2010)
PILOT STUDY OF INTRAVITREAL INJECTION OF DICLOFENAC FOR TREATMENT OF MACULAR EDEMA OF VARIOUS ETIOLOGIES
Masoud Soheilian et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
NSAIDS IN COMBINATION THERAPY FOR THE TREATMENT OF CHRONIC PSEUDOPHAKIC CYSTOID MACULAR EDEMA
Keith A. Warren et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Prediction of Vitreal Half-Life Based on Drug Physicochemical Properties: Quantitative Structure-Pharmacokinetic Relationships (QSPKR)
Chandrasekar Durairaj et al.
PHARMACEUTICAL RESEARCH (2009)
Cystoid and diabetic macular edema treated with nepafenac 0.1%
Seenu M. Hariprasad et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes
Masahiko Shimura et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c)
Katharina E. Schmid et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2006)
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema
Christos Haritoglou et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Intravitreal triamcinolone for refractory diabetic macular edema - Two-year results of a double-masked, placebo-controlled, randomized clinical trial
Mark C. Gillies et al.
OPHTHALMOLOGY (2006)
Vasoactive factors and diabetic retinopathy: Vascular endothehal growth factor, cycoloxygenase-2 and nitric oxide
JL Wilkinson-Berka
CURRENT PHARMACEUTICAL DESIGN (2004)